MedPath

PNS Vs RFA for Facet Joint Pain

Not Applicable
Not yet recruiting
Conditions
Facet Joint Pain
Interventions
Device: Sprint PNS system
Procedure: Radiofrequency Ablation
Registration Number
NCT05952518
Lead Sponsor
Penn State University
Brief Summary

Radiofrequency ablation of the medial nerve is the current surgical treatment for back pain originating from the facet joints in the spine. However, this procedure causes denervation of spinal muscles. Peripheral nerve stimulation is another treatment for facet joint pain that may not cause damage to the spinal muscles. This study will compare both treatments in terms pain relief and spine biomechanics.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  1. Age range (18-80 years): The age range of the patient population at Hershey Medical Center with facet pain is 24 to 90 years old, with a mean age of 63 years old. Due to the physical tests planned in the study, the maximum age limit will be restricted to 80 years old.
  2. English Speaking: Adults who only speak other languages will not be included because of the lack of feasibility of employing reliable instruments and interviewers fluent in other languages.
  3. Facet Joint Pain: male and female patients having a diagnosis of facet joint pain based upon accepted diagnostic criteria (i.e., two positive nerve blocks) and assessed by an experienced physical therapist or physician.
  4. Indication for Surgical Procedure: Physical therapy is the first line of action for facet joint pain. If PT is not effective, patients are eligible for RFA or PNS.
Exclusion Criteria
  1. Previous Spinal Conditions Surgery: We will exclude patients with other spinal conditions like scoliosis or who have received previous spinal surgeries.
  2. Systemic neurological or neuromuscular disease: Such disorders (e.g., stroke, muscular dystrophy, myopathies) affect muscle and may confound muscle data and/or balance and physical performance data.
  3. Allergic reaction to ultrasound gels: It is possible, although rare, that patients develop allergic reaction to ultrasound gels. Those subjects will be excluded from the study.
  4. Physical Activity: Subjects will be asked to fill out the Physical Activity Readiness Questionnaire (PAR-Q), and if they answer yes to any of the questions, they need to be cleared by their physician prior to participating in the study.
  5. Current infection, illness, or condition: Individuals with a current infection, illness, or condition (e.g., uncontrolled blood pressure, pregnancy) that may affect their ability to safely participate will be excluded.
  6. Mental incompetency: Individuals who cannot legally consent themselves to the surgical procedure and participation in the research study, will not be considered for inclusion.
  7. Patients who have a Deep Brain Stimulation (DBS) system.
  8. Patients who have an implanted active cardiac implant (e.g. pacemaker or defibrillator).
  9. Patients who have any other implantable neuro-stimulator whose stimulus current pathway may overlap with that of the SPRINT System.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Peripheral Nerve StimulationSprint PNS systemPeripheral nerve stimulation (PNS) is a procedure used to relieve chronic back pain by targeting the nerves responsible for transmitting pain signals from the back to the brain. It is a minimally invasive approach that aims to disrupt the pain signals and provide pain relief.
Radiofrequency AblationRadiofrequency AblationRadiofrequency ablation (RFA) is the current standard of care for facet joint pain. It is a minimally invasive procedure used to relieve chronic back or neck pain caused by issues with the small joints in the spine called facet joints.
Primary Outcome Measures
NameTimeMethod
Multifidus muscle activity12 months after pre-treatment measurement

Muscle contraction quantification via shear wave elastography

Secondary Outcome Measures
NameTimeMethod
Oswestry Disability Index12 months after pre-treatment measurement

Survey evaluating disability level, 0 - 4 No disability 5 - 14 Mild disability 15 - 24 Moderate disability 25 - 34 Severe disability 35 - 50 Completely disabled

2-point dixon MRI12 months after pre-treatment measurement

Intramuscular fat percentage, higher percentage means worse outcome.

Pain Intensity12 months after pre-treatment measurement

Visual Analog Scale, scale range 1 - 10, 10 being worse possible pain.

Isometric back strengthwithin two weeks of treatment completion

Measurement of peak force generated by the torso in extension in Newtons

Pfirmmann grade12 months after pre-treatment measurement

Degeneration of lumbar discs at the treated level, grade 1 - 5, 1 is normal and 5 is completely collapsed disc.

PROMIS-29 v2.012 months after pre-treatment measurement

Survey assessing pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance)

isometric back strength12 months after pre-treatment measurement

Measurement of peak force generated by the torso in extension in Newtons

Functional Reach12 months after pre-treatment measurement

distance between the length of an outstretched arm in a maximal forward reach, 10"/25 cm or greater Low risk of falls, 6"/15cm to 10"/25cm Risk of falling is 2x greater than normal, 6"/15cm or less Risk of falling is 4x greater than normal, Unwilling to reach Risk of falling is 8x greater than normal.

Repetitive Trunk Rotation12 months after pre-treatment measurement

Time to complete 20 rotations, seconds, longer times are worse performance.

Repeated Chair Stands12 months after pre-treatment measurement

Time to perform 5 repeated chair stands, higher times mean worse outcomes.

t2-relaxation time12 months after pre-treatment measurement

T2 relaxation time of the disc at the treated level. Lower values indicate more degeneration.

© Copyright 2025. All Rights Reserved by MedPath